Important changes in the field of epidemiology as a result of genotyping, identification of genetic and gene-environment causes of disease, and proteomics will ultimately influence all aspects of medical practice. The necessity for good study design, and the difference between observation and experiment, is paramount in this regard. This review discusses opportunities for molecular classification of disease that will help tailor treatment to the biologic profile of the patient and disease.
